翰森制药（03692）于2026年6月2日披露2026年5月股份变动月报表，显示公司截至2026年5月31日的注册股本与已发行股本均保持不变。
根据公告，翰森制药目前的法定/注册股本数量为20,000,000,000股，面值为每股港币0.00001，总额约为20万元。公司于5月底的已发行普通股总数为6,064,150,070股，与上月底相同，库藏股数量依旧为0股，整体股本结构未发生增发、购回或注销等变化。
期权及股权激励计划在报告期内无新增授出、行使或失效记录。公告同时显示，公司于二零二六年二月三日发行的零息可换股债券余额约为46.80亿元港币，截至2026年5月并未引发任何股份新增发行或库藏股变动。公司同时确认本月已遵守香港联交所对公众持股量的最低要求。
本次月报表由联席公司秘书钟胜利女士签署，公司声明其已遵守香港联交所《上市规则》及相关法律法规的规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.